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Test Your Memory test
Neuropsychological test
Mini-Mental State Examination
Aim: To examine the relation of performance on the self-administered Test Your Memory test (TYM) and the
Mini-Mental State Examination (MMSE) with a comprehensive neuropsychological assessment in a population
sample including people with modest cognitive decrements.
Methods: Eighty-six participants (aged 56–77 years), without known cognitive dysfunction, performed a neuro-
psychological assessment including MMSE, and were asked to ﬁll out the TYM. The relation between both the
TYM and the MMSE and a neuropsychological assessment was examined by means of correlation analyses,
area under the ROC curves for discriminating between a “normal” and “modest decrements”(≥1SD below
the sample mean) group, and Bland–Altman plots.
Results: Correlation with the full neuropsychological assessment was signiﬁcantly stronger for the TYM than the
MMSE (r = 0.78 versus r = 0.55; Steiger's Z = 2.66, p b 0.01). The TYM showed an area under the ROC-curve
of 0.88 (95% CI 0.80 to 0.97) for differentiating between “normal” and “modest decrements” compared with
0.71 (0.53 to 0.90) for the MMSE. Bland–Altman plots showed limits of agreement for the TYM of −1.10 to
1.10 and for the MMSE of −1.39 to 1.38.
Conclusions: The TYM showed good correlation with a neuropsychological assessment, performed better in
discriminating between variations of cognition and showed more agreement with a neuropsychological
assessment than the MMSE.© 2013 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Brief cognitive tests are increasingly implemented in both clinical
and research settings. They are not only used for early recognition of
cognitive deﬁcits and dementia [1], but also for measuring differences
in cognitive functioning between groups, for assessment of treatment
effects and for the detection of cognitive decline over time. For these
purposes such an instrument should not only discriminate between
dementia and normal cognitive functioning, but should also be able
to measure more subtle variations in cognitive functioning.
The most widely used brief cognitive screening test is the Mini-
Mental State Examination (MMSE) [2]. A recent addition to the available
instruments is the Test Your Memory (TYM) test [3]. This test is self-
administered by patients, takes about ﬁve minutes to complete, and
intends to measure a broad range of cognitive domains [3]. In a memoryces and Primary Care, University
A Utrecht, The Netherlands. Tel.:
Koekkoek).
vier OA license.clinic setting, the TYM showed good diagnostic value compared with the
MMSE [4,5]. Therefore, the TYM is a potentially interesting instrument to
use, particularly in settings where little time is available for the assess-
ment of cognitive functioning. One of those settings could be the practice
of a general practitioner. The range of subtle cognitive decrements in a
primary care population, however, is different from patients at the
memory clinic, with more people performing in the range of “normal”
cognitive functioning. The present study aimed to examine the relation
of the performance on the TYM and the MMSE with a comprehensive
neuropsychological assessment in a population sample including people
with modest cognitive decrements.
2. Methods
2.1. Study population
Participants took part in a cluster-randomized trial in primary care in
patients with screen-detected type 2 diabetes that compared the effec-
tiveness of an intensive treatment versus standard care on cardiovascu-
lar outcome (the ADDITION-Netherlands study) [6,7]. Cognition was
assessed in an add-on project of the main study in a subgroup of
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glucose and in people with a normal glucose level. Participants were
aged between 50 and 70 years and participants had been screened for
type 2 diabetes. Participants with normal glucose levels were relatives
of participants with diabetes. Exclusion criteria were previously diag-
nosed dementia, a known psychiatric or neurological disorder that
could inﬂuence cognitive functioning, a history of alcohol or substance
abuse or the inability to complete a neuropsychological assessment.
Participants with a previous non-invalidating stroke could participate.
During the neuropsychological examination participants were asked to
ﬁll out the TYM after they had completed a full neuropsychological as-
sessment that also included the MMSE. The present study included all
participants who completed the TYM (n = 86). The ADDITION-study
was approved by the medical ethics committee of the University Medi-
cal Center Utrecht, The Netherlands, and was completed in accordance
with the Helsinki Declaration. Written informed consent was obtained
from all participants.
2.2. Neuropsychological assessment
The neuropsychological assessment consisted of twelve verbal and
nonverbal tasks addressing six cognitive domains. The division in
cognitive domains was made a priori, according to standard neuro-
psychological practice and cognitive theory [9]. The domain ‘abstract
reasoning' was assessed by Raven Advanced Progressive Matrices.
The domain “memory” was assessed by the subtest Digit Span of
the Wechsler Adult Intelligence Scale –3rd edition (WAIS-III) [10],
the Corsi Block-tapping Task [11], the Rey Auditory Verbal Learning
Test [12], the Location Learning Test [13] and the delayed recall of
the Rey-Osterrieth Complex Figure Test [14]. The domain “informa-
tion-processing speed” was assessed by the Trail-making Test Part A
[15], the Stroop Color-Word Test (part 1 and 2 ) [16] and the subtest
Symbol Digit Substitution of the WAIS-III [10]. The domain “attention
and executive function” was assessed by the Trail-making Test Part B
(ratio score) [15], the Stroop Color-Word Test (part 3; ratio score)
[16], the Brixton Spatial Anticipation Test [17], a letter ﬂuency test
using the letters “N” and “A” and category ﬂuency (animal naming)
[18]. The domain “visuoconstruction” was assessed by the copy trial
of the Rey-Osterrieth Complex Figure Test. Finally, the domain
“language comprehension” was assessed with the Token Test (short
form) [19]. Subsequently the MMSE was administered. Educational
level was recorded in seven categories [20] and subsequently trans-
lated into years of education [21]. The tests were administered in a
ﬁxed order at the patients' home by neuropsychologists and neuro-
psychologists in training. The entire battery took about 90 minutes
to complete.
Raw test scores of the neuropsychological assessment were
standardized into z-scores per test, based on the mean and the
pooled standard deviation (SD) of the whole sample that was
included in these analyses. The individual's z-score reﬂects the
number of SDs a measurement deviates from the mean of this
sample. The z-score of each domain was calculated by averaging
all separate test z-scores comprising that domain. The cognitive
domains in the neuropsychological assessment were determined
a priori and theory-based, instead of with factor analysis. Previous
studies by our group have shown that modest differences can be
detected with these predeﬁned domains [22,23]. We preferred
this procedure above factor analysis on the data from the
neuropsychological assessment. A composite score was also calcu-
lated by averaging the z-scores of the six domains, representing a
“global cognition” score.
2.3. The Test Your Memory test
The TYM was developed to test a range of cognitive functions and
consists of 10 subtasks [3]. It is a paper-and-pencil, self-administeredtest and takes a person approximately ﬁve minutes to ﬁll out. The
tasks include orientation (10 points), ability to copy a sentence
(2 points), semantic knowledge (3 points; assessed by the questions
“who is the prime minister” and “in what year did the ﬁrst world
war start”), calculation (4 points), verbal ﬂuency (4 points), similari-
ties (4 points), naming (5 points), visuo-spatial abilities (2 tasks, total
7 points) and recall of a copied sentence (6 points). The ability to
complete the test without help provides an 11th score (5 points).
The maximum score is 50 points with lower scores indicating worse
cognitive performance. The TYM was translated into Dutch after
which a bilingual native English speaker back-translated the Dutch
version into English, which resulted in a version almost identical to
the original version.2.4. Statistical analyses
Categorical variables are reported as numbers and percent-
ages, continuous variables as means with SD and not normally
distributed variables as median with interquartile range (IQR).
Differences between groups in demographic variables and cogni-
tive scores were analyzed with Chi-square tests for categorical
variables, independent t-tests for normally distributed continuous
variables and Mann–Whitney tests for not normally distributed
continuous variables.
The relation between both the TYM and the MMSE and the neuro-
psychological assessment, which were administered consecutively,
was examined in three steps. First, the correlations between both
the TYM and the six domains of the neuropsychological assessment
and between the MMSE and the six domains as well as the composite
score of the neuropsychological assessment were examined using
Spearman correlation coefﬁcients, as the results from the TYM and
the MMSE were not normally distributed. Differences between the
correlations of the two brief cognitive tests with the neuropsycholog-
ical assessment were statistically tested by means of the Steiger's
Z-test [24]. In the primary analyses, no distinction was made between
different categories of glucose regulation (diabetes, impaired fasting
glucose, normal glucose level). However, because patients with type
2 diabetes were overrepresented in our sample and type 2 diabetes
has been associated with modest cognitive decrements [25], a sensi-
tivity analysis was performed adjusting the correlations for diabetes
status.
Second, the sample was divided into two groups based on the
scores of the neuropsychological assessment. Participants performing
1 SD or more below the mean of the whole sample on the composite
z-score were deﬁned as the group with “modest decrements”; those
with a score above −1 SD were deﬁned as “normal cognition”. This
dichotomization translates into a “below average” performance (low-
est 16%) of the total sample for the “modest decrements” group.
Based on the discrimination of these two groups, a receiver operating
characteristics (ROC) curve was plotted to assess the discriminative
power of the TYM and the MMSE respectively.
Bland and Altman illustrated that a high correlation between two
measures does not necessarily imply that they give an equally high or
low estimation of true values [26]. Therefore, in the third step agree-
ment between performance on the TYM, respectively the MMSE, and
the neuropsychological assessment was examined with Bland–
Altman plots. The mean of the measurements (x-axis) was plotted
against the difference between the two measurements (y-axis);
both expressed as standardized z-scores with the accompanying
corrected 95% limits of agreement [26]. These plots quantify the dif-
ference between performances on the TYM and the MMSE on the
one hand and the neuropsychological assessment on the other. They
create an interval in which 95% of the differences between the two in-
struments are expected to lie. A narrow 95% interval indicates greater
agreement between the tests.
Table 1
Raw neuropsychological test scores of the total sample.
Domain Test Mean ± SD Total range
Global TYM-score 44.1 ± 4.6 24–48
MMSE-score 28.8 ± 1.3 22–30
Memory WAIS-III Digit Span forwardb 49.5 ± 21.3 20–108
WAIS-III Digit Span backwardb 28.8 ± 18.8 9–96
Corsi Block-Tapping Test forwardb 41.5 ± 13.3 12–77
Corsi Block-Tapping Test backwardb 42.3 ± 13.7 12–96
RAVLT total trials 1–5 44.0 ± 10.7 20–67
RAVLT delayed recall 8.9 ± 3.3 2–15
RAVLT recognition 28.6 ± 2.1 21–30
LLT total trails 1–5a 22.8 ± 18.9 0–86
LLT learning index 0.6 ± 0.3 0.1–1
LLT delayed triala 1.9 ± 3.5 0–14
Complex Figure Test — Delay 17.7 ± 6.4 5–33
Information-processing speed Stroop Color Word Test Ia 49.8 ± 10.6 32–87
Stroop Color Word Test IIa 62.7 ± 12.2 43–112
TMT Part A 42.0 ± 17.2 16–107
WAIS-III Digit Symbol 62.1 ± 16.9 20–98
Attention and executive functioning Stroop Color Word Test IIIa 108.3 ± 28.9 64–220
TMT Part B 88.1 ± 42.8 37–272
Letter ﬂuency (mean of N + A) 12.3 ± 4.4 4–26
Category ﬂuency (animals) 32.2 ± 8.9 9–53
Brixton Spatial Anticipation Testa 16.1 ± 4.6 5–31
Abstract reasoning Raven APM 7.7 ± 2.4 1–12
Visuoconstruction Complex Figure Test — Copy 33.5 ± 2.9 20–36
Language comprehension Token test 19.0 ± 2.2 12–21
RAVLT, Rey Auditory Verbal Learning Test; LLT, Location Learning Test; TMT, Trail Making Test; WAIS-III, Wechsler Adult Intelligence Scale — Third edition; Raven APM, Raven
Advanced Progressive Matrices.
a Higher test scores reﬂect worse performance.
b Product score: span length × number of correct items.
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3.1. Study population
The TYM was completed by 86 persons of whom 46 were known
with type 2 diabetes, 11 were diagnosed with impaired fasting glu-
cose and 29 had a normal fasting glucose. Eighty-one participants
also completed the MMSE. Due to time constraints ﬁve participants
were not able to complete a MMSE. The mean age of participants
was 65.8 ± 5.4 years, 59% was male and the average years of educa-
tion was 11 ± 3 years. No differences were found for age and sex
between participants with type 2 diabetes and impaired fasting or
normal glucose. Patients with diabetes had less years of education.
Table 1 shows the raw neuropsychological test scores for the total
sample. The TYM and the MMSE scores were not normally distributed
(Kolmogorov-Smirnov: TYM z = 0.21, p b 0.001; MMSE z = 0.16,
p b 0.001). The total sample had a median TYM-score of 44 (IQR
42–48) and a MMSE-score of 29 (IQR 28–30). None of the patients
had a MMSE-score below 22 points or showed signs of dementia on
the neuropsychological assessment.Table 2
Correlations of TYM and MMSE with neuropsychological assessment within the total
sample.
TYM MMSE
r p-Value r p-Value
Composite 0.78 b0.001 0.55 b0.001
Memory 0.44 b0.001 0.38 b0.001
Information-processing speed 0.66 b0.001 0.38 0.001
Attention and executive function 0.61 b0.001 0.37 0.001
Abstract reasoning 0.54 b0.001 0.42 b0.001
Visuoconstruction 0.44 0.001 0.27 0.02
Language comprehension 0.67 b0.001 0.52 b0.001
MMSE 0.49 b0.001 – –
TYM: Test Your Memory test; MMSE: Mini-Mental State Examination.
r = Spearman correlation coefﬁcient.3.2. Correlations with a neuropsychological assessment
The correlation coefﬁcients of the TYM and the MMSE with the full
neuropsychological assessment and the individual domains are
presented in Table 2. The TYM showed a strong correlation with the
full neuropsychological assessment (r = 0.78; p b 0.001). Correla-
tions with the individual domains ranged from 0.44 to 0.67, all were
statistically signiﬁcant, with the strongest correlation for languageFig. 1. Receiver operating characteristic curve for TYM (dotted line) and MMSE
(straight line) differentiating between normal cognition and modest decrements.
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The relation between the MMSE and the full neuropsychological as-
sessment was weaker in all separate domains, ranging from 0.27 to
0.52, with the strongest correlation for language comprehension
and the weakest for visuoconstruction. In a direct comparison, the
TYM showed a statistically signiﬁcant stronger correlation with
the full neuropsychological assessment than the MMSE (Steiger's
Z =2.66; p = 0.008). The sensitivity analyses with adjustment







Fig. 2. Bland–Altman plots comparing TYM (a) and MMSE (b) with a neuropsychological as
plotted against means of the neuropsychological assessment and the TYM/MMSE (x-axis).3.3. Discriminative values of TYM and MMSE
The participants were divided in two groups to assess the discrim-
inative values of the tests for detecting mild cognitive decrements.
Compared to the “normal cognition” group (n = 73) participants in
the “moderate decrements” group (n = 13) were older (65.1 ± 5.4
versus 69.8 ± 3.9; p = 0.001) and more often male (54.8% versus
84.6%; p = 0.04). Both the TYM and the MMSE score were signiﬁ-
cantly lower in the “modest decrements” group: TYM 38 (36–43)
versus 46 (43–48), p b 0.001; MMSE 28 (27–29) versus 29 (28–30),sessment. Differences (y-axis; neuropsychological assessment minus TYM/MMSE) are
All data are expressed as standardized z-scores.
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0.88 (95%-CI 0.80 to 0.97) compared with 0.71 (95%-CI 0.53 to 0.90)
for the MMSE (Fig. 1).
3.4. Agreement of TYM and MMSE with a neuropsychological assessment
Fig. 2 shows Bland–Altman plots comparing agreement between
the TYM and the MMSE respectively and the full neuropsychological
assessment, with accompanying 95% limits of agreement. The plots
show limits of agreement for the TYM of −1.10 to 1.10 and for the
MMSE of −1.39 to 1.38, indicating that the agreement of the TYM
with the neuropsychological assessment was higher than between
the MMSE and the full assessment. The plot of the TYM shows a neg-
ative relation between the TYM and the neuropsychological assess-
ment indicating that the TYM tends to slightly underestimated the
performance at lower cognitive functioning (upper left quadrant)
and slightly overestimate performance at better cognitive functioning
(lower right quadrant).
4. Discussion
The present study provides a detailed examination of the relation
between a comprehensive neuropsychological assessment and the
TYM in a population of people without dementia and compared this
to the MMSE. The results showed that the TYM test had a stronger
correlation with a full neuropsychological assessment and its sepa-
rate cognitive domains than the MMSE. In addition, the TYM had
more discriminative power to distinguish people with modest decre-
ments from normal cognitive functioning. Analysis of agreement indi-
cated better agreement between the TYM and the neuropsychological
assessment as compared with the MMSE.
After the index-study by Brown et al., who determined the
accuracy of the TYM for discriminating patients with Alzheimer's dis-
ease from controls in a memory clinic setting [3], two other studies
also examined its diagnostic utility in a memory clinic population
[4,5]. All found good diagnostic properties for the TYM, with two
out of three ﬁnding superior values compared to the MMSE [3,5].
Brown et al. presented normal scores for the TYM of 47 and 46 points
for respectively people aged between 18 to 70 and 70 to 80 years and
a cut off score of≤42 points for Alzheimer's disease [3]. Hancock et al.
revised the optimal cut off score to≤30 points to obtain increased ac-
curacy for the detection of dementia [4]. Since the present study was
performed in a population without dementia the cut offs that were
previously established for the detection of early dementia could not
be validated in our sample. Importantly, however, our primary aim
was to compare the TYM to the MMSE in measuring variation in cog-
nitive functioning in non-demented people, rather than validation of
the cut off scores for the detection of dementia. In many studies the
MMSE is used to give a global measure of cognitive functioning
when examining the relation between risk factors and cognition or
investigating the effects of treatment on cognition [27–29]. A
meta-analysis, examining the performance of the MMSE, found that
the MMSE has limitation when used for this purpose [30]. In this
meta-analysis the MMSE distinguished only 63% of the people with
mild cognitive impairment (MCI) from healthy subjects indicating
that the MMSE is insufﬁcient measuring relatively small decline in
cognition. To examine whether the TYM could discriminate between
small decrements within the normal cognitive spectrum, we divided
the sample into two groups. People performing in the lowest 16% of
the study population were categorized as those with modest decre-
ments. The cut-off value, namely one SD, was to some extent
arbitrary and based on the sufﬁcient number of people in the modest
decrements group to allow the analyses. Nevertheless, the areas
under the ROC curve did not change signiﬁcantly with other cut off
points (data not shown). Our results suggest that the TYM is a good
alternative for examining global cognitive performance as it is moresensitive to mild decrements and it shows higher correlation and
agreement with a neuropsychological assessment. The performance
of the MMSE in measuring variation in normal cognitive functioning
has not been previously examined. The still relatively wide limits
of agreement of the Bland–Altman plots however showed that
these tests cannot simply replace a comprehensive neuropsychologi-
cal assessment.
The present study used a comprehensive neuropsychological as-
sessment in a relatively healthy population aged between 56 and
77 years. Hence, the performance of the TYM was assessed in a pop-
ulation with at most mild cognitive decrements. Whether the TYM
has similar qualities in a population that also includes patients with
more severe cognitive impairment requires further examination.
Another limitation might be the overrepresentation of patients with
diabetes. However, by including this group of patients with more
variation in cognitive functioning, we increased the contrast in the
performance range in both the neuropsychological assessment and
the screening instruments leading to valuable insight in the relation
between the instruments and a neuropsychological assessment.
Moreover, sensitivity analyses indicate that the high proportion of
individuals with diabetes did not inﬂuence our results.
In conclusion, the TYM showed good correlation with a comprehen-
sive neuropsychological assessment in people without clinically rele-
vant cognitive decrements. The TYM had more discriminative power
in discriminating between variations of cognition and showed more
agreement with a neuropsychological assessment than the MMSE.
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